← Open Payments lookup

NICOLE KEEDY: Open Payments

NPI 1194255612 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,268 in 79 payments from 17 companies in 2025. Trend: 2023 $1,305 · 2024 $1,142 · 2025 $1,268

Food & beverage: $1,268
CompanyPaymentsAmount
Janssen Biotech, Inc.28$377
ABBVIE INC.9$185
Takeda Pharmaceuticals U.S.A., Inc.13$181
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$73
Boston Scientific Corporation1$67
Phathom Pharmaceuticals, Inc.8$66
Gilead Sciences, Inc.2$58
Celltrion USA Inc.3$44
GENZYME CORPORATION2$39
Lilly USA, LLC2$37

Products named: TREMFYA, ENTYVIO, LINZESS, XIFAXAN, OverStitch Endoscopic Suturing System, VOQUEZNA, DUPIXENT, VEGZELMA.

Industry payments across NE — which companies pay providers there.